Chloroquine

NEWENTRY ; Severe acute respiratory syndrome-related coronavirus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35601684 Design, Synthesis, and Development of 4-[(7-Chloroquinoline-4-yl)amino]phenol as a Potential SARS-CoV-2 Mpro Inhibitor. 2022 Apr 21 1
2 33727943 Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study. 2021 1
3 33781188 Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2. 2021 1
4 33842834 Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs. 2021 Mar 1
5 33900318 Inhibition mechanism and hot-spot prediction of nine potential drugs for SARS-CoV-2 Mpro by large-scale molecular dynamic simulations combined with accurate binding free energy calculations. 2021 May 7 2
6 34658419 Synthesis, crystal structure, computational study and anti-virus effect of mixed ligand copper (II) complex with ONS donor Schiff base and 1, 10-phenanthroline. 2021 Dec 15 1
7 34842499 Structural and theoretical investigations, Hirshfeld surface analysis and anti-SARS CoV-2 of nickel (II) coordination complex. 2021 Nov 29 1
8 32738306 In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. 2020 Sep 2
9 32786685 Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. 2020 Nov 6 1
10 33051297 Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. 2020 Nov 3 1
11 33176880 Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). 2020 Nov 11 1